GSK3B and Alzheimer disease: In addition, mutated and overexpressed PTEN is linked with the development of cognitive impairment by constraining the expression and the activity of PP2 A. Furthermore, dysregulation of GSK3β affects Aβ, tau protein phosphorylation, synaptic plasticity, and other signaling pathways involved in the pathogenesis of AD.